Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Alopecia areata may be caused by the immune system attacking hair follicles.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Autoimmune markers may help diagnose and manage PCOS.

A woman with lupus had blood cell destruction, treated successfully with medication.

Common gene patterns may cause skin autoimmune diseases.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Infliximab may cause hair loss in Crohn's disease patients.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Clq deficiency is linked to systemic lupus erythematosus symptoms.